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Background
The HIV virus hijacks cellular machineries to replicate.
Post-translational modifications, like acetylation, phos-
phorylation or ubiquitination, are no exception. We are
interested in studying the interplay between HIV and
the SUMOylation pathway.
SUMOylation occurs via an enzymatic cascade requir-
ing an E1 activating enzyme (SAE1/SAE2 heterodimer)
and an E2 conjugating enzyme (Ubc9). This modification
is reversible thanks to SUMO isopeptidases (SENPs).
Despite Ubc9 alone being sufficient to transfer SUMO
moieties to acceptor lysine residues in vitro, E3 SUMO
ligases promote specificity and/or efficiency of SUMOyla-
tion in vivo. So far, several E3 SUMO ligases have been
characterized, such as nuclear pore complex component
Ran-binding protein 2 (RanBP2) and protein-inhibitor of
activated STAT (PIAS) family proteins.
We have recently shown that HIV integrase, the viral
enzyme that is responsible for viral genome integration
into host cellular chromosome, is SUMOylated, and
that virions harboring a SUMOylation-defective inte-
grase are less infectious than WT viruses. Our data
suggest that this modification is important for efficient
viral replication.
Materials and methods
To detect protein SUMOylation, cells expressing His-
tagged SUMO protein together with the protein of inter-
est (HIV integrase) were lysed in denaturing conditions
followed by enrichment on NiNTA colum. Bound pro-
teins were eluted by boiling in Laemmli sample buffer
supplemented with imidazole. Intracellular localization
was studied by Duo LINK approach. Protein-protein
interactions were analyzed by immunoprecipitation and
GST pull-down assays.
Results and conclusions
To better characterize the involvement of SUMOylation
during HIV replication, we are currently studying the
role of E3 SUMO ligases and SENPs in the conjugation
of SUMO to integrase. We established that HIV integrase
interacts with PIAS family member proteins and we
showed that integrase and PIAS colocalise. Moreover, we
demonstrate that PIAS1 and PIAS4, but not other PIAS
family memebers, increase whereas SENP1 decreases
integrase SUMOylation. We also analyzed the effect of
PIAS over-expression in virus-producing or target cells
and do not find a significant variation of viral infectivity.
Interestingly, during HIV infection we show a decrease of
the expression levels of one of the members of PIAS
family. Experiments are ongoing to elucidate the
mechanisms underlying this interplay between HIV and
the SUMOylation pathway.
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